Assessing the Impact of Hermetic Storage Technology on Storage Quantity and Post-Harvest Storage Losses Among Smallholding Maize Farmers in Nepal by Deepak Kumar Nepali, Keshav Lall Maharjan

Subjects: Get full text

Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12) by V. T. Ivashkin, I. G. Bakulin, P. O. Bogomolov, M. V. Matsiyevich, N. I. Geyvandova, P. V. Koroy, S. V. Nedogoda, O. A. Sablin, L. G. Lenskaya, Ye. V. Beloborodova, A. A. Bagretsova, R. A. Abdulkhakov, M. F. Osipenko, I. V. Osipova, D. A. Pocheptsov, Ye. V. Chumachek, O. M. Khromtsova, Ye. V. Kuzmicheva

“…Original study included overall 180 patients with nonalcoholic fatty liver disease that were randomized to the basic and control groups in the ratio of 2:1. …”
Get full text

Comment on “Graft Inflow Modulation by Splenic Artery Ligation for Portal Hyper Perfusion Does Not Decrease Rates of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: A Randomized Control Trial”: Can We Really Write Off Graft Inflow Modulation by Niteen Kumar, MBBS, MS, MCh, Abhideep Chaudhary, MBBS, MS, FACS, FAIS, FRCS (Glasgow)

Get full text

Attrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors-Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, India. by Sivaprakasam T Selvavinayagam, Sathish Sankar, Yean K Yong, Abdul R Anshad, Samudi Chandramathi, Anavarathan Somasundaram, Sampath Palani, Parthipan Kumarasamy, Roshini Azhaguvel, Ajith B Kumar, Sudharshini Subramaniam, Manickam Malathi, Venkatachalam Vijayalakshmi, Manivannan Rajeshkumar, Anandhazhvar Kumaresan, Ramendra P Pandey, Nagarajan Muruganandam, Natarajan Gopalan, Meganathan Kannan, Amudhan Murugesan, Pachamuthu Balakrishnan, Siddappa N Byrareddy, Aditya P Dash, Vijayakumar Velu, Marie Larsson, Esaki M Shankar, Sivadoss Raju

“…Here, we conducted a community-based, cross-sectional, cluster-randomized survey to assess anti-DENV and anti-SARS-CoV-2 seroprevalence, and also estimated the spatial distribution of DENV-positive aedine mosquito vectors during the COVID-19 pandemic across all the 38 districts of Tamil Nadu, India. …”
Get full text

Boosting skin cancer diagnosis accuracy with ensemble approach by Priya Natha, Sivarama Prasad Tera, Ravikumar Chinthaginjala, Safia Obaidur Rab, C. Venkata Narasimhulu, Tae Hoon Kim

Subjects: Get full text

Performance Optimization of Fabricated Nanosheet GAA CMOS Transistors and 6T-SRAM Cells via Source/Drain Doping Engineering by Xuexiang Zhang, Qingkun Li, Lei Cao, Qingzhu Zhang, Renjie Jiang, Peng Wang, Jiaxin Yao, Huaxiang Yin

Subjects: Get full text

Effective BCDNet-based breast cancer classification model using hybrid deep learning with VGG16-based optimal feature extraction by Meenakshi Devi P., Muna A., Yasser Ali, Sumanth V.

Subjects: Get full text

Models of industrial symbiosis formation by A. L. Belykh

Subjects: Get full text

Design of an RCT on cost-effectiveness of group schema therapy versus individual schema therapy for patients with Cluster-C personality disorder: the QUEST-CLC study protocol by Iuno Z. Groot, Anne-Sophie S. M. Venhuizen, Nathan Bachrach, Simone Walhout, Bregje de Moor, Kasper Nikkels, Susanne Dalmeijer, Myrte Maarschalkerweerd, Joël R. van Aalderen, Hinde de Lange, Renske Wichers, Agatha Ph. Hollander, Silvia M. A. A. Evers, Raoul P. P. P. Grasman, Arnoud Arntz

Subjects: Get full text

Enhancing RF Fingerprint Generation in Power Amplifiers: Unequally Spaced Multitone Design Approaches and Considerations by Chengyu Fan, Junting Deng, Ethan Chen, Vanessa Chen

Subjects: “…Combinatorial randomness (CR)…”
Get full text

Correction: Attrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors-Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, India. by Sivaprakasam T Selvavinayagam, Sathish Sankar, Yean K Yong, Abdul R Anshad, Samudi Chandramathi, Anavarathan Somasundaram, Sampath Palani, Parthipan Kumarasamy, Roshini Azhaguvel, Ajith B Kumar, Sudharshini Subramaniam, Manickam Malathi, Venkatachalam Vijayalakshmi, Manivannan Rajeshkumar, Anandhazhvar Kumaresan, Ramendra P Pandey, Nagarajan Muruganandam, Natarajan Gopalan, Meganathan Kannan, Amudhan Murugesan, Pachamuthu Balakrishnan, Siddappa N Byrareddy, Aditya P Dash, Vijayakumar Velu, Marie Larsson, Esaki M Shankar, Sivadoss Raju

Get full text

TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2− breast cancer by Heather L. McArthur, Sara M. Tolaney, Rebecca Dent, Peter Schmid, Jamil Asselah, Qiang Liu, Jane Lowe Meisel, Naoki Niikura, Yeon Hee Park, Gustavo Werutsky, Giampaolo Bianchini, Jay C. Andersen, Robert Kozarski, Nana Rokutanda, Barbara Pistilli, Sibylle Loibl

“…Design: This is an ongoing, international, phase III, open-label, randomized controlled study. Methods and analysis: Approximately 1728 patients (aged ⩾18 years) will be randomized 1:1 to eight cycles of neoadjuvant Dato-DXd (6 mg/kg intravenously (IV) every 3 weeks (Q3W)) plus durvalumab (1120 mg IV Q3W) followed by nine cycles of adjuvant durvalumab (1120 mg IV Q3W) with or without chemotherapy versus eight cycles of pembrolizumab (200 mg IV Q3W) plus chemotherapy followed by nine cycles of adjuvant pembrolizumab (200 mg IV Q3W) with or without chemotherapy. …”
Get full text

Novel Trade-offs in 5 nm FinFET SRAM Arrays at Extremely Low Temperatures by Shivendra Singh Parihar, Girish Pahwa, Baker Mohammad, Yogesh Singh Chauhan, Hussam Amrouch

Subjects: Get full text

Assessing ECG Interpretation Expertise in Medical Practitioners Through Eye Movement Data and Neuromorphic Models by Syed Mohsin Bokhari, Muhammad Shafi, Fazal Noor, Sarmad Sohaib, Saad Alqahtany, Mark Donnelly

Subjects: Get full text

Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized, observer-blind, controlled phase IIb national multicentre clinical trial: study protocol by Jan H. Driedger, Julian Schröter, PROTECT-Study Group, Steffen Syrbe, Afshin Saffari

“…Methods This two-arm, randomized, observer-blind, phase IIb national multicenter clinical trial aims at investigating the long-term neuropsychologic outcomes of pre-emptive mTOR inhibitor treatment in children diagnosed with TSC under four months of age. …”
Get full text

SMR-guided molecular subtyping and machine learning model reveals novel prognostic biomarkers and therapeutic targets in non-small cell lung adenocarcinoma by Baozhen Wang, Yichen Yin, Anqi Wang, Weidi Liu, Jing Chen, Tao Li

Subjects: Get full text

Targeted maximum likelihood based estimation for longitudinal mediation analysis by Wang Zeyi, Laan Lars van der, Petersen Maya, Gerds Thomas, Kvist Kajsa, Laan Mark van der

Subjects: Get full text

ONE OF THE WAYS OF PROCESSING AND ANALYSIS OF RESULTS OF THE PEDAGOGICAL EXPERIMENT by Elena N. Ryabinova, Yulia V. Gumennikova, Ruzilya N. Chernitsina

Subjects: Get full text

Safety, Tolerability, and Immunogenicity of the Invaplex_AR-Detox <i>Shigella</i> Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial by Geert V. T. Roozen, Nsofwa Sukwa, Masuzyo Chirwa, Jessica A. White, Marcus Estrada, Nicole Maier, Kevin R. Turbyfill, Renee M. Laird, Akamol E. Suvarnapunya, Aicha Sayeh, Flavia D’Alessio, Candice Marion, Laura Pattacini, Marie-Astrid Hoogerwerf, Rajagopal Murugan, Manuela Terrinoni, Jan R. Holmgren, Sodiomon B. Sirima, Sophie Houard, Michelo Simuyandi, Meta Roestenberg

“…Methods: In a multi-center, randomized, double-blind, and placebo-controlled dose-escalation phase Ia/b trial, the safety, tolerability, and immunogenicity of three intramuscular vaccinations administered 4 weeks apart with 2.5 µg or 10 µg of Invaplex_AR-Detox vaccine, alone or in combination with 0.1 µg of the dmLT adjuvant, will first be assessed in a total of 50 healthy Dutch adults (phase Ia) and subsequently in 35 healthy Zambian adults (phase Ib) aged 18–50 years. …”
Get full text

Evaluation of the feasibility, acceptability, and impact of Group Antenatal Care at the health post level on continuation in antenatal care and facility based delivery in Ethiopia using a cluster randomized stepped-wedge design: Study protocol [version 3; peer review: 1 approved, 3 approved with reservations, 1 not approved] by Reena Sethi, Rediet Fasil, Walelegn W. Yallew, Della Berhanu, Yenealem Woldemariam, Gayane Yenokyan, Alemayehu Worku, Dedefo Teshite, Konjit Wolde, Anne Hyre, Stephanie Suhowatsky, Lisa Noguchi

“…The study design is a stepped-wedge trial to be conducted in 36 health posts within the catchment of six health centers, with randomization of the order of the intervention introduction done at the health-center level (clusters). …”
Get full text